Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Syroco | 2024 | Series A | $7.9M | Marseille |
| Citryll | 2024 | Series B | $89.7M | Oss |
| Siit | 2024 | Seed | $5.0M | Paris |
| Otoqi | 2024 | Series B | $10.9M | Paris |
| Sequentia Biotech | 2024 | Series A | $11.2M | Barcelona |
| Sinay | 2024 | Series A | $4.1M | Caen |
| Exo | 2024 | Seed | $1.1M | Boulogne-billancourt |
| YesWeHack | 2024 | Series C | $27.9M | Paris |
| TransferGo | 2024 | Venture - Series Unknown | $10.0M | London |
| Peptobiotics | 2024 | Series A | $6.2M | Singapore |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | Syroco | Series A | $7.9M | Marseille, France |
| 27 | Citryll | Series B | $89.7M | Oss, The Netherlands |
| 28 | Siit | Seed | $5.0M | Paris, France |
| 29 | Otoqi | Series B | $10.9M | Paris, France |
| 30 | Sequentia Biotech | Series A | $11.2M | Barcelona, Spain |
| 31 | Sinay | Series A | $4.1M | Caen, France |
| 32 | Exo | Seed | $1.1M | Boulogne-billancourt, France |
| 33 | YesWeHack | Series C | $27.9M | Paris, France |
| 34 | TransferGo | Venture - Series Unknown | $10.0M | London, United Kingdom |
| 35 | Peptobiotics | Series A | $6.2M | Singapore, Singapore |
Syroco is an innovation laboratory whose mission is to improve the efficiency of the transport and energy industries.
Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.
AI-powered Service Desk solution for IT and internal operations teams
Otoqi is a vehicle delivery platform that develops connected services and logistics solutions for automotive professionals.
Sequentia Biotech is a bioinformatics company that offers services and tools that transform genomic data into knowledge.
Sinay provides numerous solutions for maritime sector stakeholders, such as collecting and analysing maritime data.
Exo mission is to promote physical exercise, a significant public health concern.
Global Bug Bounty & Vulnerability Management Platform
TransferGo offers international money transfers for both migrant workers & businesses using their digital account-to-account business model.
Peptobiotics is a synbio startup that develops livestock disease prevention biotechnology.
ID5 is an independent shared identity infrastructure for ad tech platforms and premium publishers
Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.
Nexess develops and sells security management solutions for nuclear and Seveso-type plants.
Ecto is a digital biology company developing technology to make protein production more efficient and sustainable
Pitchy is a video creation platform (SaaS B2B).
Allozymes is a biotech company that accelerating enzyme evolution for the sustainable future of industries
Hepster is an InsurTech company that focuses on the insurance sector.
Glopal is a full-stack solution for e-merchants that automatically generates incremental sales internationally.
mediarithmics is a nextgen CDP for large enterprise customers in media, retail and data centric brands
ErVimmune develops cancer vaccines and T cell therapies targeting cold tumors using AI-driven antigen discovery.
one.bio is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications.
Marcher, courir, grimper, glisser : découvrez chaque jour de nouvelles aventures sportives et le matériel pour les réaliser.
Vertero Therapeutics is using cutting-edge research outside of the brain to treat neurodegenerative illnesses.
Our cyber risk quantification platform enables Enterprises and Insurers to make more enlightened decisions about the risks they face.
Aenitis Technologies is a French start-up resulting from the work of Mauricio HOYOS
Seventure Partners has invested in 125 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Seventure Partners's top investment sectors include Biotechnology, Information Technology, Medical, Software, Health Care. The firm invests across 57 different industry categories.
Among tracked funding rounds, Citryll received $89.7M in a Series B round. Seventure Partners's total known invested capital is $1.5B.
Seventure Partners's average investment size is $18.9M across its portfolio of 125 companies.
Recent Seventure Partners portfolio additions include Syroco, Citryll, Siit, Otoqi, Sequentia Biotech. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors